Search Results 121-130 of 8410 for TNF
... tumor necrosis factor (TNF) or anti-interleukin (IL)-6 agents are excluded * Participants still recovering from toxicity of prior anticancer therapy which ...
Tumor necrosis factor receptor superfamily biology in cancer; Identification of novel drug targets, high-throughput screening for drug discovery and ...
Patient must receive anti-TNF treatment within 2 months following enrollment into the registry. Patient is currently receiving immunosuppressant therapy for ...
... Tumor Necrosis Factor (TNF) therapy. A Study to Evaluate the Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy Jacksonville, FL.
anti-Tumor necrosis factor(TNF) Monoclonal antibodies (mAb), or Belatacept, abatacept, Janus kinase inhibitors) 4. Transplant in which the kidney donor is ...
His research laboratory focuses on epigenetics, TNF-alpha and inflammatory signaling, and senescence in PKD, among other mechanisms. Funding. The Mayo Clinic ...
... tumor necrosis factor-alpha (TNF-α) antagonist for their underlying CD (does not require treatment failure for currently active draining fistula). France ...
Tumor necrosis factor-alpha (TNF- alpha) inhibitors — TNF-alpha is an inflammatory substance produced by your body. TNF-alpha inhibitors block this substance.
Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information. Participating ...
Inadequate response with, loss of response to, or intolerance to corticosteroids, immunomodulators, or Tumor necrosis factor-alpha (TNF-α) antagonists.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.